Cargando…

Hypersensitivity reaction with multi-organ failure following re-exposure to rifampicin: case report and review of the literature including WHO spontaneous safety reports

BACKGROUND: True hypersensitivity reactions to rifampicin are relatively rare, nonetheless severe manifestations mostly involving a single organ have been documented. We report a case of acute multi-organ failure occurring after a medication error with re-exposure to rifampicin. CASE PRESENTATION: A...

Descripción completa

Detalles Bibliográficos
Autores principales: Brockhaus, Lisa, Schmid, Yasmin, Rast, Anna C., Rätz Bravo, Alexandra E., Hofmeier, Kathrin Scherer, Leuppi-Taegtmeyer, Anne B.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6373162/
https://www.ncbi.nlm.nih.gov/pubmed/30755272
http://dx.doi.org/10.1186/s40360-019-0289-7
_version_ 1783394921660547072
author Brockhaus, Lisa
Schmid, Yasmin
Rast, Anna C.
Rätz Bravo, Alexandra E.
Hofmeier, Kathrin Scherer
Leuppi-Taegtmeyer, Anne B.
author_facet Brockhaus, Lisa
Schmid, Yasmin
Rast, Anna C.
Rätz Bravo, Alexandra E.
Hofmeier, Kathrin Scherer
Leuppi-Taegtmeyer, Anne B.
author_sort Brockhaus, Lisa
collection PubMed
description BACKGROUND: True hypersensitivity reactions to rifampicin are relatively rare, nonetheless severe manifestations mostly involving a single organ have been documented. We report a case of acute multi-organ failure occurring after a medication error with re-exposure to rifampicin. CASE PRESENTATION: A 68-year old patient developed acute hypersensitivity pneumonitis, acute renal failure, acute liver failure and haemolytic anemia within hours after a second re-exposure to Rifampicin for the treatment of a hip prosthesis infection with Staphylococcus epidermidis. A recent rifampicin exposure 1 week earlier had resulted in a massive rise of CRP levels without organ manifestations. Nine years previously, the patient had developed a multi-organ hypersensitivity reaction 8 days after commencing treatment with rifampicin for pulmonary tuberculosis; and 23 years previously he had received rifampicin without problems. The organ-specific hypersensitivity reactions were largely reversible after withdrawal of rifampicin and treatment with steroids. A review of the literature and summary of WHO spontaneous safety reports is also given. CONCLUSIONS: Re-exposure to rifampicin in sensitised individuals may cause acute severe hypersensitivity reactions. Due to its indications in the management of mycobacterial and implant-associated infections, rifampicin is a drug which might be given decades apart, which poses a risk that information about previous intolerance is lost.
format Online
Article
Text
id pubmed-6373162
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-63731622019-02-25 Hypersensitivity reaction with multi-organ failure following re-exposure to rifampicin: case report and review of the literature including WHO spontaneous safety reports Brockhaus, Lisa Schmid, Yasmin Rast, Anna C. Rätz Bravo, Alexandra E. Hofmeier, Kathrin Scherer Leuppi-Taegtmeyer, Anne B. BMC Pharmacol Toxicol Case Report BACKGROUND: True hypersensitivity reactions to rifampicin are relatively rare, nonetheless severe manifestations mostly involving a single organ have been documented. We report a case of acute multi-organ failure occurring after a medication error with re-exposure to rifampicin. CASE PRESENTATION: A 68-year old patient developed acute hypersensitivity pneumonitis, acute renal failure, acute liver failure and haemolytic anemia within hours after a second re-exposure to Rifampicin for the treatment of a hip prosthesis infection with Staphylococcus epidermidis. A recent rifampicin exposure 1 week earlier had resulted in a massive rise of CRP levels without organ manifestations. Nine years previously, the patient had developed a multi-organ hypersensitivity reaction 8 days after commencing treatment with rifampicin for pulmonary tuberculosis; and 23 years previously he had received rifampicin without problems. The organ-specific hypersensitivity reactions were largely reversible after withdrawal of rifampicin and treatment with steroids. A review of the literature and summary of WHO spontaneous safety reports is also given. CONCLUSIONS: Re-exposure to rifampicin in sensitised individuals may cause acute severe hypersensitivity reactions. Due to its indications in the management of mycobacterial and implant-associated infections, rifampicin is a drug which might be given decades apart, which poses a risk that information about previous intolerance is lost. BioMed Central 2019-02-12 /pmc/articles/PMC6373162/ /pubmed/30755272 http://dx.doi.org/10.1186/s40360-019-0289-7 Text en © The Author(s). 2019 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Case Report
Brockhaus, Lisa
Schmid, Yasmin
Rast, Anna C.
Rätz Bravo, Alexandra E.
Hofmeier, Kathrin Scherer
Leuppi-Taegtmeyer, Anne B.
Hypersensitivity reaction with multi-organ failure following re-exposure to rifampicin: case report and review of the literature including WHO spontaneous safety reports
title Hypersensitivity reaction with multi-organ failure following re-exposure to rifampicin: case report and review of the literature including WHO spontaneous safety reports
title_full Hypersensitivity reaction with multi-organ failure following re-exposure to rifampicin: case report and review of the literature including WHO spontaneous safety reports
title_fullStr Hypersensitivity reaction with multi-organ failure following re-exposure to rifampicin: case report and review of the literature including WHO spontaneous safety reports
title_full_unstemmed Hypersensitivity reaction with multi-organ failure following re-exposure to rifampicin: case report and review of the literature including WHO spontaneous safety reports
title_short Hypersensitivity reaction with multi-organ failure following re-exposure to rifampicin: case report and review of the literature including WHO spontaneous safety reports
title_sort hypersensitivity reaction with multi-organ failure following re-exposure to rifampicin: case report and review of the literature including who spontaneous safety reports
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6373162/
https://www.ncbi.nlm.nih.gov/pubmed/30755272
http://dx.doi.org/10.1186/s40360-019-0289-7
work_keys_str_mv AT brockhauslisa hypersensitivityreactionwithmultiorganfailurefollowingreexposuretorifampicincasereportandreviewoftheliteratureincludingwhospontaneoussafetyreports
AT schmidyasmin hypersensitivityreactionwithmultiorganfailurefollowingreexposuretorifampicincasereportandreviewoftheliteratureincludingwhospontaneoussafetyreports
AT rastannac hypersensitivityreactionwithmultiorganfailurefollowingreexposuretorifampicincasereportandreviewoftheliteratureincludingwhospontaneoussafetyreports
AT ratzbravoalexandrae hypersensitivityreactionwithmultiorganfailurefollowingreexposuretorifampicincasereportandreviewoftheliteratureincludingwhospontaneoussafetyreports
AT hofmeierkathrinscherer hypersensitivityreactionwithmultiorganfailurefollowingreexposuretorifampicincasereportandreviewoftheliteratureincludingwhospontaneoussafetyreports
AT leuppitaegtmeyeranneb hypersensitivityreactionwithmultiorganfailurefollowingreexposuretorifampicincasereportandreviewoftheliteratureincludingwhospontaneoussafetyreports